**Core Concept**
Platelet function assessment is crucial in diagnosing and managing bleeding disorders, such as thrombocytopenia, platelet dysfunction, or coagulopathy. This can be achieved through various laboratory tests that evaluate platelet count, morphology, and aggregation.

**Why the Correct Answer is Right**
The correct answer involves assessing platelet aggregation, which is a critical aspect of platelet function. Platelet aggregation is mediated by the binding of platelet glycoproteins to fibrinogen, resulting in platelet-platelet bridging and the formation of a hemostatic plug. This process is primarily regulated by the glycoprotein IIb/IIIa receptor, which has a high affinity for fibrinogen. By assessing platelet aggregation, clinicians can evaluate the effectiveness of antiplatelet therapy, monitor patients with bleeding disorders, or diagnose platelet dysfunction.

**Why Each Wrong Option is Incorrect**
**Option A:** Platelet count is measured through a complete blood count (CBC) and evaluates the number of platelets, not their function.
**Option B:** Platelet morphology is assessed through light microscopy and examines the shape and size of platelets, but does not evaluate their functional ability to aggregate.
**Option C:** Bleeding time is a clinical test that assesses the body's ability to form a hemostatic plug, but it is not specific to platelet function and can be influenced by various factors, including coagulation disorders.

**Clinical Pearl / High-Yield Fact**
Remember that platelet aggregation is a critical aspect of hemostasis, and dysfunction can lead to bleeding complications. The glycoprotein IIb/IIIa receptor is a key target for antiplatelet therapy, particularly in patients with acute coronary syndromes.

**Correct Answer: D.**